4.7 Review

The therapeutic potential of GPR43: a novel role in modulating metabolic health

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 70, Issue 24, Pages 4759-4770

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-013-1419-9

Keywords

GPR43; Short-chain fatty acids; Muscle; Adipogenesis; Obesity

Funding

  1. National Heart Foundation of Australia [PB 10 M 5472]
  2. Australian Government's Collaborative Research Networks (CRN) program

Ask authors/readers for more resources

GPR43 is a receptor for short-chain fatty acids. Preliminary data suggest a putative role for GPR43 in regulating systemic health via processes including inflammation, carcinogenesis, gastrointestinal function, and adipogenesis. GPR43 is involved in secretion of gastrointestinal peptides, which regulate appetite and gastrointestinal motility. This suggests GPR43 may have a role in weight control. Moreover, GPR43 regulates plasma lipid profile and inflammatory processes, which further indicates that GPR43 could have the ability to modulate the etiology and pathogenesis of metabolic diseases such as obesity, type 2 diabetes mellitus, and cardiovascular disease. This review summarizes the current evidence regarding the ability of GPR43 to mediate both systemic and tissue specific functions and how GPR43 may be modulated in the treatment of metabolic disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available